After day 19, 6 patients (6/17; 35.3%) administered with both rucaparib and oral contraceptives experienced grade 2 anemia, grade 2 thrombocytopenia, grade 1 abdominal pain, grade 1 nausea, grade 1 vomiting, grade 1 erythema, grade 2 increased alanine aminotransferase, and grade 3 cerebrovascular accident (1/17 each; 5.9%). The gene discussed is GPT; the disease is Thrombocytopenia.